𝔖 Bobbio Scriptorium

✦ LIBER ✦

Quadrivalent HPV L1 VLP vaccine prevents vulval, vaginal lesions

Book ID: 120846946
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715890-00023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of immune memory following adm

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

✍ Sven-Eric Olsson; Luisa L. Villa; Ronaldo L.R. Costa; Carlos A. Petta; Rosires P 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 442 KB

Safety and immunogenicity of co-administ

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

✍ Cosette M. Wheeler; Oliver M. Bautista; Joanne E. Tomassini; Margaret Nelson; Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Efficacy of a quadrivalent prophylactic

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

✍ Elmar A Joura; Sepp Leodolter; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonz 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 165 KB

PS10 Late breaking Prophylactic use of q

PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) risk

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB